Stocks
Imunon, Inc.CLSN
NASDAQHealthcareBiotechnology$1.95-0.68%
Focused on developing DNA-based immunotherapies and next-generation vaccines, this clinical-stage biotechnology firm targets infectious diseases and cancers. Investors monitor its pipeline progress, particularly its Phase 1/2 COVID-19 vaccine candidate, given the company's novel platform technology.
Market Cap: $14.5M
Congressional Interest in Imunon, Inc. (CLSN)
1 member of Congress has disclosed 4 trades in Imunon, Inc. (CLSN), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 2 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
1
Buys
2
Sells
2
Who in Congress Is Trading CLSN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-06-16 | Roger W. Marshall | buy | $1K – $15K |
| 2017-06-16 | Roger W. Marshall | sell | $1K – $15K |